Frontlight ResearchEarly access
Trial site
National Hospital Organization Kanazawa Medical Center
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis4 trials
- Peripheral artery disease2 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Obesity1 trial
- Phase
- Phase 36 trials
- Phase 2/32 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Recruiting3 trials
- Completed1 trial
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Eli Lilly and Company2 trials
- Amgen1 trial
- CSL Behring1 trial
- Pfizer1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Peripheral artery disease2 recruiting
- Chronic kidney disease1 recruiting
- Coronary artery disease1 recruiting
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026